| Harry George, Managing General PartnerHarry has more than 35 years experience in founding, operating and investing in successful rapid growth technology-related companies. He co-founded Solstice Capital. Previously, from 1981 to 1989, Mr. George was co-founder, Director, and Vice-President of Finance for Interleaf Inc. During this time, Interleaf, a pioneer in electronic publishing, grew to be a publicly traded company with $100 million in annual revenue. In January 2000, Interleaf was acquired by Broadvision in a stock merger that valued Interleaf at approximately $1 billion. Prior to this, Harry was a co-founder, Director and Vice President of Finance of Kurzweil Computer Products, subsequently purchased by Xerox Imaging Systems. Harry has been a Director of a number of private and public companies and is currently a Director of Lumidigm, High Throughput Genomics, Medipacs and Syncardia. He was active with the Arizona Venture Capital Conference, where he was on the conference screening panel from 2000-2006. Harry is a member of the Southern Arizona Leadership Council and BIO5. Harry was a member of the advisory committee of the MBA program at the Eller School of Business of the University of Arizona and serves as an advisor to the Arizona Center for Innovation. He is also a member of the Pima County Bond Advisory Committee. From 1996 to 2003, he was a Trustee of the Arizona-Sonora Desert Museum, and he currently serves as its Vice Chair of Treasure the Desert Capital Campaign. He is also a Trustee of the Tucson Museum of Art and serves as secretary-treasurer for the museum. He received an AB from Bowdoin College. |
| Henry Newman, General PartnerHenry Newman has over 35 years of venture capital investing, operations and public accounting experience. He is a co-founder of Solstice Capital, which was founded in 1995 and has raised two early-stage venture funds with total capital commitments of $79M. For more than seven years, Mr. Newman was a Vice President of BancBoston Ventures Inc., a venture capital subsidiary of Bank of Boston. Previously, he held various financial management positions at the Bank of Boston and was a CPA at Coopers & Lybrand. Mr. Newman is a Director of Regenesis Biomedical, and was formerly a Director of CodeRyte, CellzDirect, Lipton Corporate Childcare and Proton Energy Systems, Inc. Mr. Newman graduated from Bowdoin College and received an MBA from the Wharton School at the University of Pennsylvania. |